HuveGuard NB
HuveGuard NB
Authorised
- Eimeria brunetti, strain Roybru 3+28, Live
- Eimeria necatrix, strain Mednec 3+8, Live
Product identification
Medicine name:
HuveGuard NB
HuveGuard NB vet suspensio oraalisuspensiota varten kanoille
Active substance:
- Eimeria brunetti, strain Roybru 3+28, Live
- Eimeria necatrix, strain Mednec 3+8, Live
Target species:
-
Chicken
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Eimeria brunetti, strain Roybru 3+28, Live50.00oocyst(s)0.03millilitre(s)
-
Eimeria necatrix, strain Mednec 3+8, Live100.00oocyst(s)0.03millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Chicken
-
Meat and offalno withdrawal periodzero days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AN01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Finland
Available in:
-
Finland
Package description:
- Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 5 vials of 5000 doses (1 dose = 0.025 ml)
- Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 10 vials of 1000 doses (1 dose = 0.025 ml)
- Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 1 vial of 5000 doses (1 dose = 0.025 ml)
- Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 1 vial of 1000 doses (1 dose = 0.025 ml)
- Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 5 vials of 1000 doses (1 dose = 0.025 ml)
- Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminium cap. Cardboard box with 10 vials of 5000 doses (1 dose = 0.025 ml)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Biovet J.S.C.
Responsible authority:
- Finnish Medicines Agency
Authorisation number:
- 33935
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0207/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Malta
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Finnish (PDF)
Published on: 16/02/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Finnish (PDF)
Published on: 16/02/2022
How useful was this page?: